Freedom Investment Management Inc. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 43.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,430 shares of the healthcare conglomerate's stock after selling 1,873 shares during the quarter. Freedom Investment Management Inc.'s holdings in UnitedHealth Group were worth $758,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its position in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 50 shares during the period. O Brien Wealth Partners LLC grew its position in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after buying an additional 37 shares during the period. Nova Wealth Management Inc. grew its position in UnitedHealth Group by 339.1% during the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate's stock valued at $53,000 after buying an additional 78 shares during the period. Finally, Cloud Capital Management LLC purchased a new position in UnitedHealth Group during the first quarter valued at $53,000. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
NYSE:UNH opened at $362.78 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company's 50-day moving average price is $338.43 and its 200-day moving average price is $338.97. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a market cap of $328.56 billion, a P/E ratio of 15.72, a P/E/G ratio of 2.33 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period last year, the firm earned $6.80 earnings per share. UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group's payout ratio is 38.30%.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on UNH shares. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. KeyCorp increased their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an "overweight" rating in a report on Wednesday, October 8th. Zacks Research raised shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a report on Monday, October 6th. Finally, Mizuho raised their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an "outperform" rating in a research note on Thursday, October 9th. Eighteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $385.13.
Check Out Our Latest Research Report on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.